Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Review

Published on 09 Oct 2024

Insights about exosomal circular RNAs as novel biomarkers and therapeutic targets for hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Haiyan Zhang
Shanshan Pei
Jiaxuan Li
Jiajie Zhu
Hongyu Li
Guangshang Wu
Ruiqi Weng
Ruyi Chen
Zhongbiao Fang
Jingbo Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466424

2,151 views

Original Research

Published on 09 Oct 2024

Sorbaria sorbifolia flavonoid derivative induces mitochondrial apoptosis in human hepatoma cells through Bclaf1

in Pharmacology of Anti-Cancer Drugs

Jiaxin Chen
Haoyi Cheng
Chunhua Bai
Dandan Wang
Jinghao Fu
Jinge Hao
Yixuan Wang
Zhang Xuewu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1459520

829 views

Original Research

Published on 08 Oct 2024

KHSRP knockdown inhibits papillary renal cell carcinoma progression and sensitizes to gemcitabine

in Pharmacology of Anti-Cancer Drugs

Wei Song
Heng Zhang
Yi Lu
Houliang Zhang
Jinliang Ni
Lan Chang
Yongzhe Gu
Guangchun Wang
Tianyuan Xu
Zonglin Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1446920

1,216 views
2 citations

Original Research

Published on 08 Oct 2024

Multiple cell-death patterns predict the prognosis and drug sensitivity of melanoma patients

in Pharmacology of Anti-Cancer Drugs

Zewei Chen
Ruopeng Zhang
Zhoukai Zhao
Baiwei Zhao
Feiyang Zhang
Guoming Chen
Xiaojiang Chen
Chengzhi Wei
Jun Lin
Feizhi Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1295687

2,356 views

Brief Research Report

Published on 08 Oct 2024

T-cell engagers: model interrogation as a tool to quantify the interplay of relative affinity and target expression on trimer formation

in Pharmacology of Anti-Cancer Drugs

Massimo Lai
Cesar Pichardo-Almarza
Meghna Verma
Md Shahinuzzaman
Xu Zhu
Holly Kimko

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1470595

1,441 views

Original Research

Published on 02 Oct 2024

The baseline hemoglobin level is a positive biomarker for immunotherapy response and can improve the predictability of tumor mutation burden for immunotherapy response in cancer

in Pharmacology of Anti-Cancer Drugs

Yin He
Tong Ren
Chengfei Ji
Li Zhao
Xiaosheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1456833

1,176 views

Original Research

Published on 02 Oct 2024

Dehydroepiandrosterone suppresses human colorectal cancer progression through ER stress-mediated autophagy and apoptosis in a p53-independent manner

in Pharmacology of Anti-Cancer Drugs

Thi-Huong Nguyen
Huey-Jiun Ko
Po-Yu Tsai
Tai-Shan Cheng
Thu-Ha Tran
Ly Hien Doan
Michael Hsiao
Peter Mu-Hsin Chang
Hsiao-Sheng Liu
Yi-Ren Hong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464647

1,580 views
1 citation

Original Research

Published on 02 Oct 2024

DNA methylation inhibitors adverse reaction characteristic analysis: a descriptive analysis from WHO-VigiAccess

in Pharmacology of Anti-Cancer Drugs

Qiang Zhou
Quanlei Xie
Qiang Liu
Haojie Wang
Zhan Zhang
Zhao Yu
Qian Guo
Jie Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1470148

1,625 views
2 citations

Mini Review

Published on 01 Oct 2024

Assessment of ferroptosis as a promising candidate for metastatic uveal melanoma treatment and prognostication

in Pharmacology of Anti-Cancer Drugs

Ellie Swords
Breandán N. Kennedy
Valentina Tonelotto

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466896

1,602 views

Review

Published on 01 Oct 2024

RGD-based self-assembling nanodrugs for improved tumor therapy

in Pharmacology of Anti-Cancer Drugs

Bin Wang
Dongmei Tang
Jianqiao Cui
Hongfei Jiang
Jing Yu
Zhu Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477409

1,862 views
2 citations

Correction

Published on 30 Sep 2024

Corrigendum: Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis

in Pharmacology of Anti-Cancer Drugs

Burhan Ul Haq
Hina Qayoom
Shazia Sofi
Nusrat Jan
Aisha Shabir
Irshad Ahmad
Fuzail Ahmad
Abdullah Almilaibary
Manzoor A. Mir

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1494110

421 views

Review

Published on 30 Sep 2024

The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy

in Pharmacology of Anti-Cancer Drugs

Yujing Tang
Wantao Ju
Yanjun Liu
Qin Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1469830

2,894 views
3 citations

Original Research

Published on 27 Sep 2024

Interstitial lung disease associated with ALK inhibitors and risk factors: an updated comparative pharmacovigilance analysis

in Pharmacology of Anti-Cancer Drugs

Junli Dong
Lulu Li
Tiying Deng
Haibin Song
Shaohui Zhang
Minyu Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1361443

1,793 views

Review

Published on 27 Sep 2024

Diversified applications of hepatocellular carcinoma medications: molecular-targeted, immunotherapeutic, and combined approaches

in Pharmacology of Anti-Cancer Drugs

Haoyang Chen
Huihui Liu
Xiaowei Zhang
Suhua Wang
Chunxia Liu
Ke An
Ruijuan Liu
Xin Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422033

1,277 views

Perspective

Published on 26 Sep 2024

Erbin: an important therapeutic target for blocking tumor metastasis

in Pharmacology of Anti-Cancer Drugs

Tingting Qiu
Liquan Tan
Jialong Yan
Qunli Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1474798

1,545 views
1 citation

Case Report

Published on 26 Sep 2024

A case report: deep and durable response to low-dose lenvatinib and tislelizumab in an elderly patient with advanced intrahepatic cholangiocarcinoma

in Pharmacology of Anti-Cancer Drugs

Pei Zhang
Xin Wang
Ruizhen Li
Xiaoying Li
Ke Cheng
Dan Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1447582

1,010 views